Effect of heart failure on catecholamine granule morphology and storage in chromaffin cells

Journal of Endocrinology

Volumn 230, Issue 3, 2016, Pages 309-323

  Mahata, Sushil K ^a   Zheng, Hong ^b   Mahata, Sumana ^c   Liu, Xuefei ^b   Patel, Kaushik P ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Catecholamines; Chromaffin cells; Heart failure; Sympathetic activation

Indexed keywords

CATECHOLAMINE; DOPAMINE; DOPAMINE BETA MONOOXYGENASE; EPINEPHRINE; GLYCOGEN; NORADRENALIN; PHENYLETHANOLAMINE N METHYLTRANSFERASE; TYROSINE 3 MONOOXYGENASE;

ADRENAL CHROMAFFIN CELL; ADRENAL GLAND; ADRENAL MEDULLA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATECHOLAMINE RELEASE; CATECHOLAMINE SYNTHESIS; CELL METABOLISM; CELL STRUCTURE; CHROMAFFIN GRANULE; CONTROLLED STUDY; CRISTA; DENSE CORE VESICLE; EXOCYTOSIS; GOLGI COMPLEX; HEART FAILURE; HEART FUNCTION; HEART VENTRICLE; HEMODYNAMICS; IN VIVO STUDY; MALE; MEMBRANE VESICLE; MITOCHONDRION; NONHUMAN; ORGAN WEIGHT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ROUGH ENDOPLASMIC RETICULUM; SPLANCHNIC NERVE; SYNAPSE VESICLE; TRANSMISSION ELECTRON MICROSCOPY; ANIMAL; CHROMAFFIN CELL; ENDOPLASMIC RETICULUM; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ADRENAL MEDULLA; ANIMALS; CATECHOLAMINES; CHROMAFFIN CELLS; DOPAMINE; ENDOPLASMIC RETICULUM; EPINEPHRINE; EXOCYTOSIS; GOLGI APPARATUS; HEART FAILURE; MALE; MITOCHONDRIA; NOREPINEPHRINE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84986243867     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-16-0146     Document Type: Article

References (53)

1. Ahuja P, Wanagat J, Wang Z, Wang Y, Liem DA, Ping P, Antoshechkin IA, Margulies KB & Maclellan WR 2013 Divergent mitochondrial biogenesis responses in human cardiomyopathy. Circulation 127 1957-1967. (doi:10.1161/CIRCULATIONAHA.112.001219)
2. Aragones J, Fraisl P, Baes M & Carmeliet P 2009 Oxygen sensors at the crossroad of metabolism. Cell Metabolism 9 11-22. (doi:10.1016/j.cmet.2008.10.001)
3. Blandini F, Martignoni E, Sances E, Bono G & Nappi G 1995 Combined response of plasma and platelet catecholamines to different types of short-term stress. Life Sciences 56 1113-1120. (doi:10.1016/0024-3205(95)00048-B)
4. Brändle M, Patel KP, Wang W & Zucker IH 1996 Hemodynamic and norepinephrine responses to pacing-induced heart failure in conscious sinoaortic-denervated dogs. Journal of Applied Physiology 81 1855-1862
5. Clemson B, Gaul L, Gubin SS, Campsey DM, McConville J, Nussberger J & Zelis R 1994 Prejunctional angiotensin II receptors. Facilitation of norepinephrine release in the human forearm. Journal of Clinical Investigation 93 684-691. (doi:10.1172/JCI117021)
6. Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, Simon AB & Rector T 1984 Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. New England Journal of Medicine 311 819-823. (doi:10.1056/NEJM198409273111303)
7. Coupland RE 1965 Electron microscopic observations on the structure of the rat adrenal medulla: II. Normal innervation. Journal of Anatomy 99 255-272
8. de Lucia C, Femminella GD, Gambino G, Pagano G, Allocca E, Rengo C, Silvestri C, Leosco D, Ferrara N & Rengo G 2014 Adrenal adrenoceptors in heart failure. Frontiers in Physiology 5 246. (doi: 10.3389/fphys.2014.00246)
9. Driessen B & Starke K 1994 Modulation of neural noradrenaline and ATP release by angiotensin II and prostaglandin E2 in guinea-pig vas deferens. Naunyn Schmiedebergs Archives of Pharmacology 350 618-625
10. Eisenhofer G, Friberg P, Rundqvist B, Quyyumi AA, Lambert G, Kaye DM, Kopin IJ, Goldstein DS & Esler MD 1996 Cardiac sympathetic nerve function in congestive heart failure. Circulation 93 1667-1676. (doi:10.1161/01.CIR.93.9.1667)
11. Elman I, Goldstein DS, Adler CM, Shoaf SE & Breier A 2001 Inverse relationship between plasma epinephrine and testosterone levels during acute glucoprivation in healthy men. Life Sciences 68 1889-1898. (doi:10.1016/S0024-3205(01)00982-1)
12. Ferguson DW, Berg WJ & Sanders JS 1990 Clinical and hemodynamic correlates of sympathetic nerve activity in normal humans and patients with heart failure: evidence from direct microneurographic recordings. Journal of the American College of Cardiology 16 1125-1134. (doi:10.1016/0735-1097(90)90544-Y)
13. Goldstein DS, Eisenhofer G & Kopin IJ 2003 Sources and significance of plasma levels of catechols and their metabolites in humans. Journal of Pharmacology and Experimental Therapeutics 305 800-811. (doi:10.1124/jpet.103.049270)
14. Guo X & Wakade AR 1994 Differential secretion of catecholamines in response to peptidergic and cholinergic transmitters in rat adrenals. Journal of Physiology 475 539-545. (doi:10.1113/jphysiol.1994. sp020092)
15. Handschin C, Rhee J, Lin J, Tarr PT & Spiegelman BM 2003 An autoregulatory loop controls peroxisome proliferator-activated receptor gamma coactivator 1alpha expression in muscle. PNAS 100 7111-7116. (doi:10.1073/pnas.1232352100)
16. Hasking GJ, Esler MD, Jennings GL, Burton D & Korner PI 1986 Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardio-renal sympathetic nervous activity. Circulation 73 615-621. (doi:10.1161/01.CIR.73.4.615)
17. Johnson DG, Hayward JS, Jacobs TP, Collis ML, Eckerson JD & Williams RH 1977 Plasma norepinephrine responses of man in cold water. Journal of Applied Physiology: Respiratory, Environmental and Exercise Physiology 43 216-220
18. Kamal FA, Mickelsen DM, Wegman KM, Travers JG, Moalem J, Hammes SR, Smrcka AV & Blaxall BC 2014 Simultaneous adrenal and cardiac g-protein-coupled receptor-gbetagamma inhibition halts heart failure progression. Journal of the American College of Cardiology 63 2549-2557. (doi:10.1016/j.jacc.2014.02.587)
19. Karamanlidis G, Nascimben L, Couper GS, Shekar PS, del Monte F & Tian R 2010 Defective DNA replication impairs mitochondrial biogenesis in human failing hearts. Circulation Research 106 1541-1548. (doi:10.1161/CIRCRESAHA.109.212753)
20. Kleiber AC, Zheng H, Schultz HD, Peuler JD & Patel KP 2008 Exercise training normalizes enhanced glutamate-mediated sympathetic activation from the PVN in heart failure. American Journal of Physiology: Regulatory, Integrative and Comparative Physiology 294 R1863-1872. (doi: 10.1152/ajpregu.00757.2007)
21. Kline RL, Patel KP & Mercer PF 1986 Enhanced noradrenergic activity in the kidney of brattleboro rats with diabetes insipidus. American Journal of Physiology 250 R567-R572
22. Kvetnansky R, Weise VK, Thoa NB & Kopin IJ 1979 Effects of chronic guanethidine treatment and adrenal medullectomy on plasma levels of catecholamines and corticosterone in forcibly immobilized rats. Journal of Pharmacology and Experimental Therapeutics 209 287-291
23. Lymperopoulos A, Rengo G, Gao E, Ebert SN, Dorn GW, 2nd & Koch WJ 2010 Reduction of sympathetic activity via adrenaltargeted GRK2 gene deletion attenuates heart failure progression and improves cardiac function after myocardial infarction. Journal of Biological Chemistry 285 16378-16386. (doi:10.1074/jbc.M109.077859)
24. Mahata SK, Mahata M, Wakade AR & O'Connor DT 2000 Primary structure and function of the catecholamine release inhibitory peptide catestatin (chromogranin A(344-364)): identification of amino acid residues crucial for activity. Molecular Endocrinology 14 1525-1535. (doi: 10.1210/me.14.10.1525)
25. Mannelli M, Gheri RG, Selli C, Turini D, Pampanini A, Giusti G & Serio M 1982 A study on human adrenal secretion. Measurement of epinephrine, norepinephrine, dopamine and cortisol in peripheral and adrenal venous blood under surgical stress. Journal of Endocrinological Investigation 5 91-95. (doi: 10.1007/bf03350497)
26. Mirkin BL 1961 Factors influencing the selective secretion of adrenal medullary hormones. Journal of Pharmacology and Experimental Therapeutics 132 218-225
27. Neubauer S 2007 The failing heart-an engine out of fuel. New England Journal of Medicine 356 1140-1151. (doi:10.1056/NEJMra063052)
28. Oakes SA & Papa FR 2015 The role of endoplasmic reticulum stress in human pathology. Annual Review of Pathology 10 173-194. (doi:10.1146/annurev-pathol-012513-104649)
29. Pacak K, Palkovits M, Yadid G, Kvetnansky R, Kopin IJ & Goldstein DS 1998 Heterogeneous neurochemical responses to different stressors: a test of Selye's doctrine of nonspecificity. American Journal of Physiology 275 R1247-1255
30. Packer M 1988 Neurohormonal interactions and adaptations in congestive heart failure. Circulation 77 721-730. (doi:10.1161/01.CIR.77.4.721)
31. Pasqua T, Mahata S, Bandyopadhyay GK, Biswas A, Perkins GA, Sinha-Hikim AP, Goldstein DS, Eiden LE & Mahata SK 2016 Impact of Chromogranin A deficiency on catecholamine storage, catecholamine granule morphology and chromaffin cell energy metabolism in vivo. Cell and Tissue Research 363 693-712. (doi:10.1007/s00441-015-2316-3)
32. Patel KP 1997 Neural regulation in experimental heart failure. Bailliere's Clinical Neurology 6 283-296
33. Patel KP, Zhang K & Carmines PK 2000 Norepinephrine turnover in peripheral tissues of rats with heart failure. American Journal of Physiology: Regulatory, Integrative and Comparative Physiology 278 R556-R562
34. Puigserver P & Spiegelman BM 2003 Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. Endocrine Reviews 24 78-90. (doi:10.1210/er.2002-0012)
35. Rengo G, Leosco D, Zincarelli C, Marchese M, Corbi G, Liccardo D, Filippelli A, Ferrara N, Lisanti MP, Koch WJ, et al. 2010 Adrenal GRK2 lowering is an underlying mechanism for the beneficial sympathetic effects of exercise training in heart failure. American Journal of Physiology: Heart and Circulatory Physiology 298 H2032-H2038. (doi: 10.1152/ajpheart.00702.2009)
36. Rettig J & Neher E 2002 Emerging roles of presynaptic proteins in Ca++-triggered exocytosis. Science 298 781-785. (doi:10.1126/science.1075375)
37. Revel JP, Napolitano L & Fawcett DW 1960 Identification of glycogen in electron micrographs of thin tissue sections. Journal of Biophysical and Biochemical Cytology 8 575-589. (doi:10.1083/jcb.8.3.575)
38. Rundqvist B, Elam M, Bergmann-Sverrisdottir Y, Eisenhofer G & Friberg P 1997 Increased cardiac adrenergic drive precedes generalized sympathetic activation in human heart failure. Circulation 95 169-175. (doi:10.1161/01.CIR.95.1.169)
39. Scarpulla RC 2008 Transcriptional paradigms in mammalian mitochondrial biogenesis and function. Physiological Reviews 88 611-638. (doi:10.1152/physrev.00025.2007)
40. Scheffler IE 2008 Mitochondria. New York: John Wiley & Sons, Inc
41. Schneider J, Lother A, Hein L & Gilsbach R 2011 Chronic cardiac pressure overload induces adrenal medulla hypertrophy and increased catecholamine synthesis. Basic Research in Cardiology 106 591-602. (doi:10.1007/s00395-011-0166-z)
42. Sengupta D & Linstedt AD 2011 Control of organelle size: the Golgi complex. Annual Review of Cell and Developmental Biology 27 57-77. (doi:10.1146/annurev-cellbio-100109-104003)
43. Smith CB & Eiden LE 2012 Is PACAP the major neurotransmitter for stress transduction at the adrenomedullary synapse? Journal of Molecular Neuroscience 48 403-412. (doi:10.1007/s12031-012-9749-x)
44. Stroth N, Kuri BA, Mustafa T, Chan SA, Smith CB & Eiden LE 2013 PACAP controls adrenomedullary catecholamine secretion and expression of catecholamine biosynthetic enzymes at high splanchnic nerve firing rates characteristic of stress transduction in male mice. Endocrinology 154 330-339. (doi:10.1210/en.2012-1829)
45. Tank AW & Lee Wong D 2015 Peripheral and central effects of circulating catecholamines. Comprehensive Physiology 5 1-15. (doi: 10.1002/cphy. c140007)
46. Taupenot L, Mahata M, Mahata SK & O'Connor DT 1999 Timedependent effects of the neuropeptide PACAP on catecholamine secretion: stimulation and desensitization. Hypertension 34 1152-1162. (doi:10.1161/01.HYP.34.5.1152)
47. Taupenot L, Mahata SK, Wu H & O'Connor DT 1998 Peptidergic activation of transcription and secretion in chromaffin cells. Cis and trans signaling determinants of pituitary adenylyl cyclase-activating polypeptide (PACAP). Journal of Clinical Investigation 101 863-876. (doi:10.1172/JCI1129)
48. Tomaszek A, Kiczak L, Bania J, Paslawska U, Zacharski M, Janiszewski A, Noszczyk-Nowak A, Dziegiel P, Kuropka P, Ponikowski P, et al. 2015 Increased gene expression of catecholamine-synthesizing enzymes in adrenal glands contributes to high circulating catecholamines in pigs with tachycardia-induced cardiomyopathy. Journal of Physiology and Pharmacology 66 227-231
49. Vander Heiden MG, Cantley LC & Thompson CB 2009 Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324 1029-1033. (doi:10.1126/science.1160809)
50. Wakade AR 1988 Noncholinergic transmitter(s) maintains secretion of catecholamines from rat adrenal medulla for several hours of continuous stimulation of splanchnic neurons. Journal of Neurochemistry 50 1302-1308. (doi:10.1111/j.1471-4159.1988. tb10608.x)
51. Wende AR, Schaeffer PJ, Parker GJ, Zechner C, Han DH, Chen MM, Hancock CR, Lehman JJ, Huss JM, McClain DA, et al. 2007 A role for the transcriptional coactivator PGC-1alpha in muscle refueling. Journal of Biological Chemistry 282 36642-36651. (doi:10.1074/jbc.M707006200)
52. Zhang K, Li YF & Patel KP 2001 Blunted nitric oxide-mediated inhibition of renal nerve discharge within PVN of rats with heart failure. American Journal of Physiology: Heart and Circulatory Physiology 281 H995-H1004
53. Zucker IH, Wang W, Brändle M, Schultz HD & Patel KP 1995 Neural regulation of sympathetic nerve activity in heart failure. Progress in Cardiovascular Diseases 37 397-414. (doi: 10.1016/s0033-0620(05)80020-9)